Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other - PubMed (original) (raw)
Review
Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other
David A Horwitz et al. Trends Immunol. 2008 Sep.
Abstract
Foxp3(+) CD4(+) CD25(+) regulatory cell (Treg) subsets that maintain immunologic homeostasis have been considered to be a homogeneous population of naturally occurring, thymus-derived CD4(+)CD25(+) cells (nTregs). However, similar Foxp3+ Tregs can be induced from CD25(-) precursors in vivo, and ex vivo with interleukin 2 (IL-2) and transforming growth factor beta (TGF-beta) (iTregs). These two subsets differ in their principal antigen specificities and in the T-cell receptor signal strength and co-stimulatory requirements needed for their generation. However, whether iTregs have any unique functions in vivo has been unclear. Although IL-6 can convert nTregs to Th17 cells, iTregs induced by IL-2 and TGF-beta are resistant to this cytokine and thereby might retain suppressive function at inflammatory sites. Thus, nTregs and iTregs may have different roles in the adaptive immune response.
Similar articles
- Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
Su H, Ye DQ, Wang BL, Fang XH, Chen J, Wang Q, Li WX, Zhang N. Su H, et al. Br J Dermatol. 2008 Jun;158(6):1197-209. doi: 10.1111/j.1365-2133.2008.08555.x. Epub 2008 Apr 10. Br J Dermatol. 2008. PMID: 18410422 - Adaptive Treg generation by DCs and their functional analysis.
Wang L. Wang L. Methods Mol Biol. 2010;595:403-12. doi: 10.1007/978-1-60761-421-0_26. Methods Mol Biol. 2010. PMID: 19941127 - Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N, Tang L, Li X, Wu D, Li W, Chen X, Cui L, Ba D, He W. Kang N, et al. Immunol Lett. 2009 Aug 15;125(2):105-13. doi: 10.1016/j.imlet.2009.06.005. Epub 2009 Jun 17. Immunol Lett. 2009. PMID: 19539651 - Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease.
Horwitz DA, Zheng SG, Gray JD, Wang JH, Ohtsuka K, Yamagiwa S. Horwitz DA, et al. Semin Immunol. 2004 Apr;16(2):135-43. doi: 10.1016/j.smim.2003.12.009. Semin Immunol. 2004. PMID: 15036237 Review. - The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road.
Zhang L, Zhao Y. Zhang L, et al. J Cell Physiol. 2007 Jun;211(3):590-7. doi: 10.1002/jcp.21001. J Cell Physiol. 2007. PMID: 17311282 Review.
Cited by
- Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects.
Zhang H, Felthaus O, Eigenberger A, Klein S, Prantl L. Zhang H, et al. Cells. 2024 Sep 11;13(18):1526. doi: 10.3390/cells13181526. Cells. 2024. PMID: 39329710 Free PMC article. Review. - Targeting tumor-infiltrating tregs for improved antitumor responses.
Qin D, Zhang Y, Shu P, Lei Y, Li X, Wang Y. Qin D, et al. Front Immunol. 2024 Mar 4;15:1325946. doi: 10.3389/fimmu.2024.1325946. eCollection 2024. Front Immunol. 2024. PMID: 38500876 Free PMC article. Review. - Immunomodulatory effects of canine mesenchymal stem cells in an experimental atopic dermatitis model.
Kang SJ, Gu NY, Byeon JS, Hyun BH, Lee J, Yang DK. Kang SJ, et al. Front Vet Sci. 2023 Jul 13;10:1201382. doi: 10.3389/fvets.2023.1201382. eCollection 2023. Front Vet Sci. 2023. PMID: 37529178 Free PMC article. - Immune Response and Molecular Mechanisms of Cardiovascular Adverse Effects of Spike Proteins from SARS-CoV-2 and mRNA Vaccines.
Bellavite P, Ferraresi A, Isidoro C. Bellavite P, et al. Biomedicines. 2023 Feb 3;11(2):451. doi: 10.3390/biomedicines11020451. Biomedicines. 2023. PMID: 36830987 Free PMC article. Review. - COVID-19 immunotherapy: Treatment based on the immune cell-mediated approaches.
Zavvar M, Yahyapoor A, Baghdadi H, Zargaran S, Assadiasl S, Abdolmohammadi K, Hossein Abooei A, Reza Sattarian M, JalaliFarahani M, Zarei N, Farahvash A, Fatahi Y, Deniz G, Zarebavani M, Nicknam MH. Zavvar M, et al. Int Immunopharmacol. 2022 Jun;107:108655. doi: 10.1016/j.intimp.2022.108655. Epub 2022 Feb 25. Int Immunopharmacol. 2022. PMID: 35248946 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials